Insider · CIK 0001701998
Jonathan Adam Feldschuh
Files at DXR (DAXOR CORP). First filing -, latest -.
Jonathan Adam Feldschuh files SEC Form 4 as officer and director at DXR (DAXOR CORP). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jonathan Adam Feldschuh has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | DXR DAXOR CORP | AGrant or award Daxor Common Stock | +25,000 | $0.00 | $0 | 78,908 | Jun 25, 2026 |
| Dec 9, 2025 | DXR DAXOR CORP | POpen-market purchase Daxor Common Stock | +18,000 | $0.00 | $0 | 53,908 | Dec 11, 2025 |
| Dec 6, 2024 | DXR DAXOR CORP | POpen-market purchase Daxor Common Stock | +32,000 | $0.00 | $0 | 35,908 | Dec 10, 2024 |
Questions about Jonathan Adam Feldschuh
Answered from the filings on this page, as of the latest one.
Is Jonathan Adam Feldschuh buying or selling?
Jonathan Adam Feldschuh has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jonathan Adam Feldschuh's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jonathan Adam Feldschuh has 0.
Where does Jonathan Adam Feldschuh file Form 4?
Jonathan Adam Feldschuh has filed Form 4 at DXR (DAXOR CORP) as Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.